About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Updates on the Treatment Approach for MCL
Updates on the Treatment Approach for MCL
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
L
Disease Progression in Mantle Cell Lymphoma
By
Lauren Pinter-Brown
4 Videos
291 views
October 11, 2022
This video was recorded prior to FDA approval of Pirtobrutinib on January 26, 2023 in
...
read more ↘
Mantle Cell Lymphoma.
↖ read less
0 Comments
Login to view comments.
Click here to Login
Updates on the Treatment Approach for MCL
09:38
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Long-Term Outcomes of Adults With R/R B-A…
Feat.
B. Shah
15:47
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "SWOG S1826 - Rationale, Results, and Clin…
Feat.
A. Evens
11:12
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…
Feat.
A. Herrera
09:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…
Feat.
J. Westin
09:45
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …
Feat.
M. Kamdar
34:28
Indy Hematology Review
Advancing Therapeutic Outcomes in Aggressive B and T Cell Lymphomas
Feat.
T. Phillips
07:08
VCU Massey Cancer Center
Recent Advances in the Treatment of MCL
Feat.
V. Yazbeck
38:55
Indy Hematology Review
Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…
Feat.
G. Salles
10:51
Kami Maddocks
Sequencing Treatment for R/R MCL
29:22
UChicago Medicine
Updates on MCL and CAR-T
Feat.
P. Riedell
09:00
Thomas McFarlane
Targeting and Treatment of MCL
24:04
Yale Cancer Center
Updates on Allogeneic Stem Cell Transplant
Feat.
L. Bachegowda
11:19
The University of Alabama at Birmingham School of Medicine
Mantle Cell Lymphoma: Unmet Needs & Latest Therapeutical Insights
Feat.
A. Mehta
12:54
The University of Alabama at Birmingham School of Medicine
Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing C…
Feat.
M. Narkhede
15:01
Yazeed Sawalha
Novel Combinations for the Treatment of Patients With R/R MCL: Promi…
19:16
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023
Chemo and Non-Chemo Treatment of Mantle Cell Lymphoma
Feat.
M. Wang
09:47
Icahn School of Medicine at Mount Sinai
What's the Difference? Covalent vs. Non-Covalent BTKis in MCL
Feat.
J. Brody
05:24
Chan Cheah
Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…
25:29
19th Annual International Ultmann Chicago Lymphoma Symposium
Mantle Cell Lymphoma: Case-Based Approach to Management
Feat.
R. Karmali
07:11
Lauren Pinter-Brown
Disease Progression in Mantle Cell Lymphoma
07:48
City of Hope
Tolerability of BTKi in R/R MCL
Feat.
T. Phillips
10:36
ASH 2022 Conference Coverage
The CAR-HEMATOTOX Score Identifies Patients at High Risk for Hematol…
Feat.
K. Rejeski
12:42
University of Colorado Cancer Center
Management of Patients With R/R MCL
Feat.
M. Kamdar
06:35
ASH 2022 Conference Coverage
Results From a Phase 1/2 Study of Tandem, Bispecific Anti-CD20/Anti-…
Feat.
N. Shah
08:54
ASH 2022 Conference Coverage
ECOG-ACRIN E1411: A Randomized Phase 2 Trial of First-Line Bendamust…
Feat.
M. Smith
06:16
City of Hope
Current Perspective on CAR-T Therapy in Mantle Cell Lymphoma
Feat.
A. Danilov
